Rajesh Shah’s journey is one of quiet perseverance, principled grit, and visionary risk-taking.
Divine Life Care Pvt Ltd Micro Facility 2015
The Business Journey:
Rajesh Shah founded Divine Formulations in 1996, later incorporated as Divine Life Care Pvt. Ltd. By 2002, he established an independent WHO-GMP-compliant
manufacturing facility in Sanand, Ahmedabad, spanning 45,000 sq. ft.
The unit focused on quality manufacturing rather than scale, emphasizing sterile environments, validated processes, and ethical production.
Under his leadership, Divine Life Care grew to manufacture over 300 formulations across five therapeutic divisions, supplying companies and distributors across India.
A Landmark Innovation (2013–2014)
The Trade-Secret Formulation:
In 2013–2014, drawing on his decades of practical pharmaceutical insight, Rajesh Shah developed a novel oral drink composition of Sildenafil Citrate designed to overcome
long-standing challenges of solubility, palatability, and chemical degradation in liquid dosage forms.
The Composition:
Sildenafil Citrate + Dextrose + Sodium Benzoate + Sodium Citrate (± Citric Acid)
This proprietary blend created a self-stabilizing, osmotic, and pH-balanced system—a pioneering advance in the field of PDE-5 inhibitor formulations.
Why It Mattered
| Function |
Role in the Formulation |
Impact |
| Dextrose |
Acts as osmotic carrier and stabilizer preventing crystallization |
Enhances absorption and taste, enables isotonic profile |
| Sodium Benzoate |
Functions as antimicrobial preservative in acid range |
Ensures shelf stability without alcohol or parabens |
| Sodium Citrate + Citric Acid |
Dual buffer system maintaining pH ~4.5–5.0 |
Preserves potency, prevents precipitation, balances taste |
| Sildenafil Citrate (API) |
Therapeutic PDE-5 inhibitor |
Efficacy and safety retained in liquid form |
Collective Effect:
A sugar-based, alcohol-free, room-temperature-stable oral drink—an entirely new class of Sildenafil formulation
that could serve both medical and nutraceutical categories.
---
Distinctive Advantages
* Ambient shelf stability > 24 months under ICH Zone IVb conditions.
* Faster absorption and onset (≈ 15–20 minutes) due to dextrose-induced osmotic transport.
* Improved patient compliance for geriatric and dysphagic users.
* Halal and alcohol-free composition suitable for global markets.
* Regulatory potential: NDDS / 505(b)(2) classification under “novel excipient combination.”
This composition—when integrated into broader medical and neural systems—holds the potential to transform therapeutic delivery and adaptive response models.
It represents not merely a formulation but a biochemical framework with far-reaching implications for future drug-delivery research.
---
### Challenges and Continuity
Despite its clear scientific merit, the formulation faced regulatory and market suppression during its time due to political and competitive interference from entrenched pharmaceutical players.
With limited legal avenues for registering a *trade-secret formulation* then, commercialization was paused—even though the invention had passed internal pilot validation.
Today, with modern trade-secret protection laws, NDDS recognition, and data-exclusivity frameworks available, this proprietary formula stands ready to be
re-manufactured, validated, and introduced to market under full legal and ethical compliance.
---------------------------------------------------------------------------------
Rajesh Shah began his professional journey in 1984 as a Medical Representative, covering the rural and urban belts of Gujarat on a
modest Luna moped with a 12-kilogram medical sample bag. From these
humble beginnings, he learned every dimension of India’s pharmaceutical ecosystem—prescriber behavior, distribution
dynamics, and the power of ethical marketing.
During his early years, he worked with some of the country’s most respected pharmaceutical organizations, including:
SDL India (Dhootapapeshwar Ltd.)
BPL (British Pharmaceutical Laboratories)
PCI (Pharmaceutical Company of India)
Lupin (Ahmedabad HQ)
Through persistent effort and deep understanding of the trade, he rose to the position of All-India Marketing Head at Sharda Drugs Public Ltd.,
leading national-level marketing operations and product strategy.
---
### Legacy of Divine Life Care Pvt. Ltd.
* Founded: 1996
* Manufacturing Unit Established: 2002
* Location: Sanand, Ahmedabad, Gujarat
* Facility Size: 45,000 sq.ft.
* Certification: WHO-GMP (2016)
* Product Portfolio: 300 + formulations
* Specialization: Tablets, Capsule, Liquid, Ointment, Powder, and niche NDDS prototypes
Divine Life Care’s success symbolizes what disciplined entrepreneurship, ethical practice, and scientific curiosity can achieve even without external funding.
---
### In Summary
Rajesh Shah’s professional arc—from a field representative in 1984 to a WHO-GMP-certified manufacturer and inventor in 2013—embodies the rare blend of field insight,
technical mastery, and ethical leadership.
His 2013/2014 trade-secret invention of the Sildenafil + Dextrose + Sodium Benzoate + Sodium Citrate formulation stands as a benchmark for how traditional
pharmaceutical experience can yield world-changing, stable, and accessible drug-delivery innovations.
> *A life devoted to medicine, discipline, and the relentless pursuit of better formulations.*
Smatter Headlines: Awaiting Smatter3FA Security Defense Clearance and Security Vetting : 11 November 2025
Today, as Smatter LLP prepares to introduce its invention breakthroughs to the world, the narrative
surrounding Rajesh Shah and his success from Job to business in the pharmaceutical industry overlooks the critical role of compact, compliant, and highly efficient units
like Divine Life Care Pvt Ltd, which began with just one or two niche products like Ofloxacin Infusion and scaled to over
300 formulations across five therapeutic divisions.
Mr. Parth Shah's Journey So Far:
Since we started, Smatter has focused on meaningful innovations in communication and data security. Here’s a look
at some of the solutions we’ve created:
1. Declaration of Inventorship (2015–2025)
Year Short Name Full Title / Core Concept
2015 SerenePay Serene Payroll — Biometric salary automation for workforce management.
com.serenepay.serenepay
2016 ProminerGST Prominer GST Software (Java) — Centralized GST Management System with adaptive compliance engine.
https://github.com/shahparth1111/ProminerGST
2017 MonopolyPay Monopoly Dummy Transfer — Educational money simulation app for academic institutions.
com.prominergroup.imonopoly.ibank_monopoly
2018 CalorieCounter OCR-based nutrition and calorie computation system.
2018–2019 Smatter Smatter — Multi-language messaging ecosystem with offline grammar processor and translation engine.
app.smatter.smatter
2019 Smatter Document Translation Structure-preserving document translation via OCR (image-to-text architecture).
https://www.youtube.com/watch?v=PrlmS51y3rM
2019–2020 Sequel5 Cross-platform multiplayer gaming system for Android, iOS, Web, and Smart TV.
https://sequel5.com
2020 MysteryCaller Anonymous AI-driven call router and dynamic auto-routing system.
com.mystery.mystery
2020 ATR (All Time Recorder) Continuous segmented voice recording system with 5-minute rolling log architecture.
com.blairstudios.saferec
2021-
2022 Smatter Time Encryption Keyless, quantum-safe encryption system built on temporal identity logic.
WIPO Patent: PCT/IN2023/050389 Novelty Granted
2021–2022 Dual-Cycle QR Sign-On Dual-phase QR-based authentication establishing user’s physical presence validation.
TradeSecret Part of: OShreeji Dental Clinic -
https://apps.apple.com/gb/app/oshreeji-dental-clinic/id1586462168
2022–2023 Smatter Data Compression 1 ZB/YB → 1 KB ultra-compression algorithm authorized under India
Foreign Filling License (Permission No. FA/1126/MUM/2023) – NO DEFENSE OR ATOMIC – Government of India
2023 AlgoStockTrading Adaptive AI trading system based on real-time algorithmic prediction models.
com.smatter.algostocktrading
2024/25 Smatter 3FA Smatter Three-Factor Authentication (STE-based) — Passwordless login integrating Smatter Time Encryption (Live: 28 Oct 2025, 11:14 AM).
app.smatter.smatter3fa
2025 Smatter Document Fingerprint Document fingerprinting verification (each page) system – Global - Affidavit/Notary (In process).
app.smatter.smatterdocumentfingerprint
2025 Investment Equity Vision (IEV) AI-based stock market and investment insight engine (In process).
app.smatter.investmentequityvision
StraviQ Ltd - (February 2025 to Present)
https://straviq.com
Looking Ahead
At Smatter, we’re always pushing forward. Next, we’re working on a powerful data compression algorithm that could reduce massive data sizes (like 1 PB/1 ZB) to
1 KB.
